title: Changes in bile acids metabolism during rat hepatocarcinogenesis: causative or unrelated?
abstract: In the present paper, we have aimed at studying the variations in the metabolism of bile acids occurring during an hepatocarcinogenic process induced in male Wistar Rats by the biphasic protocol of Solt and Farber. Bile acids concentrations was measured in the liver. The most significant changes have been observed 5 weeks after the beginning of the treatment, it means one week after the selection treatment consisting in 2-acetylaminofluorene administration: the increase in cholic acid, and of its intestinal metabolite, deoxycholic acid, and of alpha- and beta- muricholic acids, are likely to be a consequence of an acute effect of 2-acetylaminofluorene. To test for the putative implication of liver bile acids modifications in the selection effect of 2-acetylaminofluorene, diethyl-nitrosamine-pretreated rats were fed a diet containing 1% lithocholic acid, a treatment that induces essentially the same qualitative changes in liver bile acids, as 2-acetylaminofluorene does: no selection effect of lithocholic acid could be demonstrated. These results suggest that changes in bile acid metabolism occurring early in hepatocarcinogenesis are more likely to be secondary than causative events. The same conclusion comes from the results obtained later on in the process, where there is only a high increase in liver cholic acid and deoxycholic acid concentrations.
authors.affiliation: Dpt. des Sciences Pharmaceutiques, Université Catholique de Louvain, Brussels, Belgium.
authors.forename: N M
authors.initials: NM
authors.lastname: Delzenne
authors.forename: H S
authors.initials: HS
authors.lastname: Taper
authors.forename: M B
authors.initials: MB
authors.lastname: Roberfroid
mesh_terms: D015073:2-Acetylaminofluorene / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001647:Bile Acids and Salts / Q000097:blood / Q000378:metabolism*; D019826:Cholic Acid; D002793:Cholic Acids / Q000378:metabolism; D003840:Deoxycholic Acid / Q000378:metabolism; D004052:Diethylnitrosamine; D008095:Lithocholic Acid / Q000008:administration & dosage / Q000494:pharmacology; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051381:Rats; D017208:Rats, Wistar
chemical_list: D001647:Bile Acids and Salts; D002793:Cholic Acids; D003840:Deoxycholic Acid; C004821:muricholic acid; D004052:Diethylnitrosamine; D008095:Lithocholic Acid; D015073:2-Acetylaminofluorene; D019826:Cholic Acid